Regulatory T Cell Mimicry by a Subset of Mesenchymal GBM Stem Cells Suppresses CD4 and CD8 Cells
Attempts to activate an anti-tumor immune response in glioblastoma (GBM) have been met with many challenges due to its inherently immunosuppressive tumor microenvironment. The degree and mechanisms by which molecularly and phenotypically diverse tumor-propagating glioma stem cells (GSCs) contribute...
Saved in:
| Main Authors: | Amanda L. Johnson, Harmon S. Khela, Jack Korleski, Sophie Sall, Yunqing Li, Weiqiang Zhou, Karen Smith-Connor, John Laterra, Hernando Lopez-Bertoni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/8/592 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasmapheresis, immunosuppressive therapy and anti-GBM disease prognosis: a cohort study of 107 patients
by: Ying Liu, et al.
Published: (2024-12-01) -
The Role of Insulin Receptor Substrate 4 (IRS4) Protein in the Radiotherapy Response of Glioblastoma Multiforme (GBM) Cells
by: Gökhan Görgişen, et al.
Published: (2024-10-01) -
Immunoregulation mechanism of Treg cells in anti-GBM glomerulonephritis model of mice
by: ZHOU Huan, et al.
Published: (2017-01-01) -
Decoding clinical diversity in monogenic TGFBR1 and TGFBR2 mutations: insights into the interplay of molecular mechanisms and hypomorphicity
by: Fadia Abu-Sailik, et al.
Published: (2025-06-01) -
In Lower‐Grade Gliomas, the SPARC Family Exacerbates Prognosis by Influencing Immunity, Stemness, and Metabolism
by: Qiaoying Peng, et al.
Published: (2025-08-01)